Displaying results 1-10 of 125

• ASBMB Today Article
  Gain-of-function research: All in the eye of the beholder
  Nov. 21, 2021
  

  Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
• ASBMB Today Article
  Society news briefs: November 2021
  Nov. 16, 2021
  

  Find out everything that’s been going on lately at the American Society for Biochemistry and Molecular Biology.
• ASBMB Today Article
  Antibiotic resistance is at a crisis point
  Nov. 7, 2021
  

  Government support for academia and Big Pharma to find new drugs could help defeat superbugs
• ASBMB Today Article
  Dalit scientists face barriers in India’s top science institutes
  Oct. 23, 2021
  

  Despite decades-old inclusion policies, Dalits are systematically underrepresented in science institutes in India. Why?
• ASBMB Today Article
  A salary with strings attached
  Oct. 22, 2021
  

  Here's what you need to know about postdoc payback agreements.
• ASBMB Today Article
  Land acknowledgments meant to honor Indigenous people too often do the opposite
  Oct. 22, 2021
  

  Instead, they erase American Indians and sanitize history.
• ASBMB Today Article
  On-the-bench training
  Oct. 20, 2021
  

  Apprenticeships offer pathways into biotechnology for a growing number of students. How does the training model work, why are policymakers excited about it, and who wants to be an apprentice?
• ASBMB Today Article
  COVID immunity through infection or vaccination: Are they equal?
  Oct. 16, 2021
  

  As scientists argue whether a previous bout of covid offers the same amount of protection as vaccinations, people turn to the courts to decide.
• ASBMB Today Article
  Society news briefs: October 2021
  Oct. 14, 2021
  

  Find out everything that’s been going on lately with the American Society for Biochemistry and Molecular Biology.
• ASBMB Today Article
  Collins’ skillful piloting helped NIH steer clear of political minefields
  Oct. 9, 2021
  

  Francis Collins, who is stepping down as chief of the National Institutes of Health, used his communication skills and political insights to help protect the acclaimed federal research institutes through difficult times.